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Editorial on the Research Topic
Antimicrobial Peptides - Interaction with Membrane Lipids and Proteins
Antimicrobial peptides (AMPs) are a natural class of antibiotics that are present in all domains of
life (Hancock and Chapple, 1999). AMPs are part of the innate immune system and possess not only
antibacterial but also antiviral, antifungal, antiparasitic, and anticancer activity and often exhibit
immune-modulatory properties (Zasloff, 2002). There is astonishingly little resistance to these
ancient antibiotic molecules (Yeaman and Yount, 2003), despite the fact that they occur in virtually
all organisms and already exist for hundreds of millions of years (Lehrer, 2013). Therefore, AMPs
are considered a key weapon in fighting antibiotic-resistant pathogens (Brogden and Brogden,
2011).
One reason for this remarkable insensitivity to the buildup of resistance is that many AMPs
target the cell envelope, i.e., either the cytoplasmic or outer membrane, or the peptidoglycan cell
wall (Brogden, 2005). These are very complex and essential structures, which cannot easily change
without substantial loss of function (Hurdle et al., 2011). Another reason is that by targeting
the cytoplasmic membrane, AMPs disturb multiple processes simultaneously. E.g., the cellular
response to aurein peptides showed upregulation of membrane and cell wall stress responses, fatty
acid and membrane synthesis, central carbon metabolism, motility, and chemotaxis (Wenzel et al.,
2015), and it has been demonstrated that inhibition of membrane function also affects metabolic
pathways due to energy depletion (Spindler et al., 2011).
The vast majority of mode of action studies on AMPs has focused on their interaction with
model membranes resulting in a multitude of models to explain the formation of membrane pores
(Yeaman and Yount, 2003). While the “barrel-stave” (Melo et al., 2009), “toroidal pore” (van’t Hof
et al., 2001) or “carpet models” (Steiner et al., 1988) provide insight into interaction of amphipathic
α-helical peptides with lipid bilayers, the “molecular electroporation” (Miteva et al., 1999), “sinking
raft” (Pokorny et al., 2002), “interfacial activity” (Wimley, 2010), and “lipocentric pore formation”
(Fuertes et al., 2011) models are more applicable for small, unstructured, or compact peptides
that are unable to span the lipid bilayer to form a pore directly. However, there is increasing
evidence that many peptides are not forming pores in bacteria at all and that the membrane
disruption observed in vitro is only part of the picture (Scheinpflug et al., 2015). The hexapeptide
RWRWRW-NH2 was shown to inhibit cell wall synthesis and respiration by displacing involved
proteins from the membrane (Wenzel et al., 2014), and the last resort lipopeptide antibiotic
daptomycin was found to insert into fluid membrane microdomains and delocalize phospholipid
and cell wall synthesis enzymes (Müller et al., 2016). Thus, in order to thoroughly understand the
mechanisms of action of AMPs, it is necessary to view biological membranes as a whole, including
membrane organization and protein localization. The articles in this collection cover studies on
AMP interaction with membrane components both in vitro and in vivo as well as boosting AMP
activity and evaluating their cytotoxicity.
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One major challenge in the development of AMPs as novel
drugs is enhancing their activity against Gram-negative bacteria.
A nice example is the study by Bluhm et al., who were able to
optimize apidaecins, insect-derived peptides that interfere with
ribosome assembly, toward higher activity against Pseudomonas
aeruginosa, which has an intrinsically high antibiotic resistance
and is on its way to pan-resistance. In fact, it is an important
limitation of many antibiotics, not only AMPs, that they are not
very effective against Gram-negative bacteria, a consequence of
their outer membrane barrier. Zhou et al. addressed this issue by
fusing the amino acid sequences of peptides that are known to
permeate the outer membrane to the C-terminus of the potent
lantibiotic nisin, generating molecules with two-fold enhanced
activity against Gram-negatives. Lantibiotics are an extremely
interesting class of AMPs, since many of them specifically bind
cell wall precursors to exert their membrane activity, resulting
in remarkable selectivity for bacterial over mammalian cells
(Schneider and Sahl, 2010). While many new peptides are
screened for cytotoxicity, it has now been demonstrated that
this initial screening needs to be improved. A case in point
is the hexapeptide RWRWRW-NH2, which was not toxic or
hemolytic in earlier studies (Albada et al., 2012), but failed the
acute toxicity test in mice. Although it only leads to minor release
of hemoglobin from erythrocytes, which was interpreted as mild
hemolytic potential, damaged erythrocyte membranes can easily
be observed under the microscope (Wenzel et al.).
The mechanism of AMPs has been investigated on the
molecular level by Ciesielski et al., who provided new insight
into how amphotericin B and natamycin recognize membrane
sterols using 13C MAS NMR (Ciesielski et al.), and by Grage
et al., who showed that membrane thinning, which has been
proposed as part of the mode of action of AMPs (Grage et al.,
2010), is a valid concept for some peptides but depends on
both the individual peptide and the lipid bilayer and cannot be
generalized (Grage et al.). For cellular mode of action studies,
te Winkel et al. provided detailed guidance on how to analyze
the capacity of membrane-active compounds to dissipate the
membrane potential in bacteria using voltage-sensitive dyes. The
broad range of antibacterial mechanisms of AMPs and the stress
response of bacteria toward these molecules has been extensively
reviewed by Omardien et al. Finally, the growing evidence that
AMPs are not just unselectively disrupting membrane bilayers
but actually targeting specialized membrane foci is discussed by
Rashid et al.
In conclusion, AMPs are a structurally and mechanistically
diverse group of promising antibiotic agents with great
clinical potential. More and more evidence is emerging
that their mechanisms involve a much wider variety of
interactions with membrane components than previously
assumed. This research topic has brought together different
viewpoints of AMP research from molecules to systems
and we hope that this collection will promote future
collaborations across fields to investigate these promising
compounds.
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